Related Experiment Video
Updated: Aug 9, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Coronary thrombolytic therapy: state of the art
Insights
Thrombolytic therapy can limit heart damage from acute coronary artery thrombosis and myocardial infarction. This review covers thrombolytic agents, administration methods, and future research for ischemic heart disease.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Ischemic heart disease is a leading cause of death in the US.
- Acute coronary artery thrombosis leading to myocardial infarction causes significant myocardial damage.
Purpose of the Study:
- To review current concepts of thrombolytic therapy for acute myocardial infarction.
- To discuss mechanisms, administration routes, and outcomes of thrombolytic agents.
Main Methods:
- Review of current literature on thrombolytic therapy.
- Analysis of action mechanisms of major thrombolytic agents.
- Evaluation of intracoronary thrombolytic therapy techniques and results.
Main Results:
- Thrombolytic therapy offers a means to reduce myocardial damage during acute coronary events.
- Intravenous and intracoronary administration routes have different clinical implications.
- Post-thrombolytic management of coronary artery disease is crucial.
Conclusions:
- Thrombolytic therapy is a vital treatment for acute myocardial infarction.
- Ongoing research focuses on novel agents and optimized therapeutic strategies.
- Future investigations aim to further improve outcomes for patients with ischemic heart disease.
Abstract:
Ischemic heart disease remains a significant cause of morbidity and mortality in the United States. Thrombolytic therapy has given physicians the capability of limiting the amount of myocardial damage that occurs when there is an acute coronary artery thrombosis and resulting myocardial infarction. This review summarizes current concepts about action mechanisms of the major thrombolytic agents, the technique and clinical results of intracoronary thrombolytic therapy, intravenous vs intracoronary administration, postthrombolytic management of underlying coronary artery disease, new agents being developed, and directions for future investigations.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Angina IV: Management

